In addition, downregulation of HIF-1α in RCC cells promotes tumor growth, and supplementing HIF-1α deficient cell lines with HIF-1α leads to tumor regression (Shen et al., 2011). The gene discussed is HIF1A; the disease is renal cell carcinoma.